News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,545 Results
Type
Article (87725)
Company Profile (824)
Press Release (777977)
Multimedia
Podcasts (185)
Webinars (28)
Section
Business (233164)
Career Advice (4142)
Deals (39830)
Drug Delivery (144)
Drug Development (91345)
Employer Resources (203)
FDA (18346)
Job Trends (17414)
News (397676)
Policy (39946)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (166)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (301)
Approvals (18434)
Artificial intelligence (576)
Autoimmune disease (128)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (186)
Biotechnology (487)
Bladder cancer (149)
Brain cancer (61)
Breast cancer (587)
Cancer (4600)
Cardiovascular disease (405)
Career advice (3564)
Career pathing (39)
CAR-T (288)
CDC (59)
Cell therapy (779)
Cervical cancer (36)
Clinical research (76424)
Collaboration (1569)
Company closure (5)
Compensation (1052)
Complete response letters (64)
COVID-19 (2974)
CRISPR (93)
C-suite (724)
Cystic fibrosis (147)
Data (5710)
Decentralized trials (2)
Denatured (67)
Depression (131)
Diabetes (490)
Diagnostics (7160)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (221)
Earnings (99871)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134449)
Executive appointments (1009)
FDA (21151)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1420)
Gene editing (201)
Generative AI (59)
Gene therapy (615)
GLP-1 (1079)
Government (5417)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (270)
Immuno-oncology (34)
Indications (72)
Infectious disease (3242)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (214)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (641)
Lymphoma (357)
Machine learning (40)
Management (66)
Manufacturing (732)
MASH (164)
Medical device (14963)
Medtech (15001)
Mergers & acquisitions (22860)
Metabolic disorders (1273)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (319)
Neuropsychiatric disorders (85)
Neuroscience (2935)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (607)
Opinion (324)
Ovarian cancer (152)
Pain (183)
Pancreatic cancer (196)
Parkinson's disease (267)
Partnered (34)
Patents (462)
Patient recruitment (391)
Peanut (58)
People (66599)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23597)
Phase II (33176)
Phase III (24995)
Pipeline (3730)
Policy (318)
Postmarket research (3554)
Preclinical (10655)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (790)
Real estate (7435)
Recruiting (80)
Regulatory (28486)
Reports (65)
Research institute (2713)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (147)
Series A (232)
Series B (177)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1099)
Venture capital (76)
Weight loss (427)
Women's health (75)
Worklife (21)
Date
Today (179)
Last 7 days (723)
Last 30 days (2911)
Last 365 days (33445)
2025 (32081)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (84)
Alaska (7)
Arizona (324)
Arkansas (14)
Asia (51286)
Australia (9011)
California (10719)
Canada (3139)
China (1037)
Colorado (452)
Connecticut (478)
Delaware (320)
Europe (117898)
Florida (1572)
Georgia (346)
Hawaii (3)
Idaho (68)
Illinois (883)
India (62)
Indiana (516)
Iowa (22)
Japan (372)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1392)
Massachusetts (7952)
Michigan (339)
Minnesota (620)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2935)
New Mexico (32)
New York (2869)
North Carolina (1524)
North Dakota (10)
Northern California (5040)
Ohio (324)
Oklahoma (22)
Oregon (52)
Pennsylvania (2176)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4116)
Tennessee (165)
Texas (1676)
United States (39031)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (903)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
There are 866,545 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium
December 10, 2025
·
9 min read
Press Releases
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
December 10, 2025
·
10 min read
Press Releases
Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors
December 10, 2025
·
11 min read
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
December 10, 2025
·
7 min read
Press Releases
Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants
December 10, 2025
·
5 min read
Vaccines
FDA Launches Probe Into Safety of Approved Anti-RSV Antibodies
The FDA has informed Merck, Sanofi and AstraZeneca of the safety investigation into their RSV antibodies, though it remains unclear what regulatory action, if any, will be taken.
December 10, 2025
·
2 min read
·
Tristan Manalac
Approvals
First Commissioner’s Priority Review Approval Goes to GSK’s Decades-Old Antibiotic
The Commissioner’s National Priority Voucher program was launched in June to shorten review times for companies that align with various national priorities, such as improving domestic drug production and supply.
December 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
PreludeDx Announces First Independent Validation of AidaBreast™, the Only Multi-Omic Test to Predict Locoregional Recurrence Risk and Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer
December 10, 2025
·
5 min read
Press Releases
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
December 10, 2025
·
6 min read
Press Releases
Fondazione Telethon Announces FDA approval of Waskyra™ (etuvetidigene autotemcel), a Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome
December 10, 2025
·
5 min read
1 of 86,655
Next
